Compare · FHLT vs HIMS
FHLT vs HIMS
Side-by-side comparison of Future Health ESG Corp. (FHLT) and Hims & Hers Health Inc. (HIMS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both FHLT and HIMS operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- HIMS carries a market cap of $3.76B.
- HIMS has hit the wire 28 times in the past 4 weeks while FHLT has been quiet.
- HIMS has more recent analyst coverage (25 ratings vs 0 for FHLT).
- Company
- Future Health ESG Corp.
- Hims & Hers Health Inc.
- Price
- -
- -
- Market cap
- -
- $3.76B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- 2019
- News (4w)
- 0
- 28
- Recent ratings
- 0
- 25
Future Health ESG Corp.
Future Health ESG Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Dover, Delaware.
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Latest FHLT
- Future Health ESG Corp. filed SEC Form 8-K: Leadership Update
- SEC Form NT 10-Q/A filed by Future Health ESG Corp. (Amendment)
- Future Health ESG Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- Polar Asset Management Partners Inc. sold $14,947 worth of shares (1,255 units at $11.91) (SEC Form 4)
- SEC Form NT 10-Q filed by Future Health ESG Corp.
- SEC Form SC 13D filed by Future Health ESG Corp.
- Future Health Esg Associates 1, Llc sold 1,703,486 shares, decreasing direct ownership by 65% to 921,514 units (SEC Form 4)
- Morgan Travis A sold 2,079,245 shares (SEC Form 4)
- Bostic Bradley sold 2,079,245 shares (SEC Form 4)
- SEC Form SC 13G/A filed by Future Health ESG Corp. (Amendment)
Latest HIMS
- Chief Legal Officer Soleil Boughton sold $64,077 worth of shares (3,458 units at $18.53) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 311,190 units (SEC Form 4)
- Chief Policy Officer Deborah M. Autor sold $441,533 worth of shares (23,828 units at $18.53) as part of a pre-agreed trading plan, decreasing direct ownership by 33% to 48,961 units (SEC Form 4)
- Chief Financial Officer Oluyemi Okupe sold $65,189 worth of shares (3,518 units at $18.53) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 266,188 units (SEC Form 4)
- Hims & Hers Launches Peptides+, a New Clinically-Guided Specialty for Access to Personalized, Proactive Health
- Director Christopher D Payne converted options into 810 shares, increasing direct ownership by 2% to 35,673 units (SEC Form 4)
- Chief Legal Officer Soleil Boughton converted options into 42,262 shares and covered exercise/tax liability with 21,500 shares, increasing direct ownership by 7% to 314,648 units (SEC Form 4) (tax withholding)
- CTO Mohamed Elshenawy converted options into 188,286 shares and covered exercise/tax liability with 95,798 shares, increasing direct ownership by 50% to 278,044 units (SEC Form 4) (for withholding tax)
- Chief Medical Officer Patrick Harrison Carroll converted options into 25,927 shares and covered exercise/tax liability with 10,200 shares, increasing direct ownership by 8% to 213,574 units (SEC Form 4) (for tax liability)
- Chief Policy Officer Deborah M. Autor converted options into 39,974 shares and covered exercise/tax liability with 16,146 shares, increasing direct ownership by 49% to 72,789 units (SEC Form 4) (withholding obligation)
- Chief Operating Officer Michael Chi converted options into 69,769 shares and covered exercise/tax liability with 38,581 shares, increasing direct ownership by 7% to 487,848 units (SEC Form 4) (tax withholding)